rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-1-23
|
pubmed:abstractText |
Chronic endothelial cell loss of the graft is very common after penetrating keratoplasty. The aetiology of this is unknown. Clinically, non-identifiable immune reactions have been suspected. Recently, we were able to demonstrate that proper human leucocyte antigen (HLA) matching is a suitable means to reduce classical immune reactions in normal risk keratoplasty patients. In this study, we therefore investigated whether HLA-matched grafts also experience less chronic endothelial cell loss.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1395-3907
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-8
|
pubmed:dateRevised |
2008-3-17
|
pubmed:meshHeading |
pubmed-meshheading:14738484-Cell Count,
pubmed-meshheading:14738484-Chronic Disease,
pubmed-meshheading:14738484-Endothelium, Corneal,
pubmed-meshheading:14738484-Female,
pubmed-meshheading:14738484-Graft Survival,
pubmed-meshheading:14738484-Histocompatibility Antigens Class I,
pubmed-meshheading:14738484-Histocompatibility Antigens Class II,
pubmed-meshheading:14738484-Histocompatibility Testing,
pubmed-meshheading:14738484-Humans,
pubmed-meshheading:14738484-Keratoplasty, Penetrating,
pubmed-meshheading:14738484-Male,
pubmed-meshheading:14738484-Middle Aged,
pubmed-meshheading:14738484-Postoperative Complications,
pubmed-meshheading:14738484-Risk Factors,
pubmed-meshheading:14738484-Tissue Donors
|
pubmed:year |
2004
|
pubmed:articleTitle |
HLA class I/II matching and chronic endothelial cell loss in penetrating normal risk keratoplasty.
|
pubmed:affiliation |
Eye Hospital, Albert-Ludwigs University, Freiburg, Germany. Reinhard@aug.ukl.uni-freiburg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|